Y-MABS THERAPEUTICS INC (YMAB) Stock Cash Flow
NASDAQ:YMAB - Nasdaq - US9842411095 - Common Stock - Currency: USD
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -23.86M | -21.43M | -95.57M | -55.28M | -119.34M | |||
| Depreciation Amortization | 598.00K | 735.00K | 840.00K | 780.00K | 400.00K | |||
| Change In Working Capital | -11.87M | -19.73M | -10.37M | -7.28M | 3.44M | |||
| Taxes Paid | N/A | 367.00K | N/A | N/A | N/A | |||
| Other non cash items | 13.26M | 13.19M | 29.18M | -40.78M | 24.27M | |||
| OPERATING CASH FLOW | -21.88M | -27.23M | -75.92M | -102.56M | -91.23M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | N/A | N/A | 0.00 | -970.00K | -180.00K | |||
| Other Investing Activity | N/A | N/A | 0.00 | 62.01M | -2.61M | |||
| INVESTING CASH FLOW | N/A | N/A | 0.00 | 61.04M | -2.79M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 3.42M | 100.00K | 80.00K | 108.31M | 2.00M | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 3.42M | 100.00K | 80.00K | 108.31M | 2.00M | |||
| Exchange Rate Effect | 1.00K | 7.00K | 40.00K | 130.00K | -490.00K | |||
| CHANGE IN CASH | -18.45M | -27.13M | -75.80M | 66.92M | -92.51M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -21.88M | -27.23M | -75.92M | -102.56M | -91.23M | |||
| Capital Expenditure | N/A | N/A | 0.00 | -970.00K | -180.00K | |||
| FREE CASH FLOW | -21.88M | -27.23M | -75.92M | -103.53M | -91.41M | |||
All data in USD